World Wires · story 72361 · corroborated · 1 source(s)

Moderna mRNA vaccine almost halves risk of skin cancer returning

Phase III trial results show that Moderna's mRNA vaccine significantly reduces the risk of skin cancer returning in patients with treatment-resistant melan

Open in the desk

Coverage

• Moderna mRNA vaccine almost halves risk of skin cancer returning Nature · tier B · clear net · 2026-10-23 00:00 UTC

What this site indexes